{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:56:43Z","timestamp":1787579803342,"version":"build-2736575974"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH"},{"name":"NIH"},{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development"},{"name":"NIH","award":["5R21HD074462"],"award-info":[{"award-number":["5R21HD074462"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Infect Dis."],"published-print":{"date-parts":[[2016,3,15]]},"DOI":"10.1093\/cid\/civ1001","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T13:32:46Z","timestamp":1449667966000},"page":"675-682","source":"Crossref","is-referenced-by-count":85,"title":["Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks"],"prefix":"10.1093","volume":"62","author":[{"given":"Kimberly K.","family":"Scarsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin M.","family":"Darin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadia","family":"Nakalema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Back","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Byakika-Kibwika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Else","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujan","family":"Dilly Penchala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Buzibye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepta","family":"Merry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Lamorde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"key":"2016030108084836000_62.6.675.1","unstructured":"World Health Organization. Global summary of the AIDS epidemic, December 2014. Available at: http:\/\/www.who.int\/hiv\/data\/epi_core_july2015.png?ua=1 . Accessed 14 September 2015."},{"key":"2016030108084836000_62.6.675.2","unstructured":"UNAIDS. How AIDS changed everything\u2014MDG6: 15 years, 15 lessons of hope from the AIDS response. Available from: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/MDG6Report_en.pdf . Accessed 5 September 2015."},{"key":"2016030108084836000_62.6.675.3","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000194602.01058.e1"},{"key":"2016030108084836000_62.6.675.4","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2008.030049"},{"key":"2016030108084836000_62.6.675.5","unstructured":"World Health Organization. Medical eligibility criteria for contraceptive use, 5th edition 2015. Available at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/181468\/1\/9789241549158_eng.pdf?ua=1 Accessed 15 September 2015."},{"key":"2016030108084836000_62.6.675.6","unstructured":"World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization, 2013."},{"key":"2016030108084836000_62.6.675.7","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Geneva: World Health Organization, 2015."},{"key":"2016030108084836000_62.6.675.8","unstructured":"World Health Organization Policy Brief. Transition to new HIV treatment regimens\u2014procurement and supply chain management issues. Geneva: World Health Organization. 2014."},{"key":"2016030108084836000_62.6.675.9","unstructured":"Reproductive Health Supplies Coalition. Available at: http:\/\/rhsupplies.org . Accessed 12 September 15."},{"key":"2016030108084836000_62.6.675.10","unstructured":"Jadelle [package insert]. Auckland, New Zealand: Bayer New Zealand Limited Company. August 2010."},{"key":"2016030108084836000_62.6.675.11","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/137192"},{"key":"2016030108084836000_62.6.675.12","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31822b8bf8"},{"key":"2016030108084836000_62.6.675.13","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000177"},{"key":"2016030108084836000_62.6.675.14","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http:\/\/aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf . Accessed 14 September 2015."},{"key":"2016030108084836000_62.6.675.15","unstructured":"World Health Organization. WHO statement on progestogen-only implants. Geneva: World Health Organization. September 2015. Available at: http:\/\/apps.who.int\/iris\/bitstream\/10665\/190063\/1\/WHO_RHR_15.20_eng.pdf?ua=1 . Accessed 23 November 2015."},{"key":"2016030108084836000_62.6.675.16","unstructured":"World Health Organization. Medical eligibility criteria for contraceptive use, 4th ed. Geneva: World Health Organization, 2009."},{"key":"2016030108084836000_62.6.675.17","unstructured":"Uganda Ministry of Health. Addendum to the national antiretroviral treatment guidelines. Kampala: Uganda Ministry of Health, December 2013."},{"key":"2016030108084836000_62.6.675.18","unstructured":"US Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS. Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 2.0. 2014. Available at: http:\/\/rsc.tech-res.com\/Document\/safetyandpharmacovigilance\/DAIDS_AE_GRADING_TABLE_v2_NOV2014.pdf . Accessed 15 September 2015."},{"key":"2016030108084836000_62.6.675.19","unstructured":"US Food and Drug Administration. Bioanalytical Method Validation. September 2013. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM368107.pdf . Accessed 5 September 2015."},{"key":"2016030108084836000_62.6.675.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(96)00276-4"},{"key":"2016030108084836000_62.6.675.21","first-page":"4","article-title":"Updated guidelines to perform therapeutic drug monitoring for antiretroviral agents","volume":"3","author":"La Porte","year":"2006","journal-title":"Rev Antiviral Ther"},{"key":"2016030108084836000_62.6.675.22","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000189"},{"key":"2016030108084836000_62.6.675.23","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(15)00184-8"},{"key":"2016030108084836000_62.6.675.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.09.005"},{"key":"2016030108084836000_62.6.675.25","doi-asserted-by":"publisher","DOI":"10.1783\/147118907782101724"},{"key":"2016030108084836000_62.6.675.26","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2009.009469"},{"key":"2016030108084836000_62.6.675.27","doi-asserted-by":"publisher","DOI":"10.1783\/147118910791749164"},{"key":"2016030108084836000_62.6.675.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(97)00153-4"},{"key":"2016030108084836000_62.6.675.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(01)00226-8"},{"key":"2016030108084836000_62.6.675.30","unstructured":"World Health Organization. Hormonal contraceptive methods for women at high risk of HIV and living with HIV: 2014 guidance statement. Geneva: World Health Organization."},{"key":"2016030108084836000_62.6.675.31","unstructured":"World Health Organization. Strategic considerations for strengthening and linkages between family planning and HIV\/AIDS policies, programs, and services. Available at: http:\/\/www.who.int\/reproductivehealth\/publications\/linkages\/fp_hiv_strategic_considerations.pdf . Accessed 21 December 2015."},{"key":"2016030108084836000_62.6.675.32","unstructured":"Center for Drug Evaluation and Research (2003). Guidance for industry: bioavailability and bioequivalence studies for orally administered drug products\u2014general considerations. US Food and Drug Administration. Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/03\/briefing\/3995B1_07_GFI-BioAvail-BioEquiv.pdf. Accessed 21 December 2015."},{"key":"2016030108084836000_62.6.675.33","doi-asserted-by":"publisher","DOI":"10.9745\/GHSP-D-12-00003"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/62\/6\/675\/16789074\/civ1001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T05:39:39Z","timestamp":1589607579000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/civ1001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,8]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,3,1]]},"published-print":{"date-parts":[[2016,3,15]]}},"alternative-id":["10.1093\/cid\/civ1001"],"URL":"https:\/\/doi.org\/10.1093\/cid\/civ1001","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,8]]}}}